CTSB and Alzheimer disease: Abnormalities in the miR‐96‐5p/CTSB signaling pathway were detected in the serum of both mild cognitive impairment and AD patients, and the combination of serum miR‐96‐5p and CTSB demonstrated strong diagnostic efficacy for cognitive impairment (AUC = 0.7536).